Article
Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Mar 2000
Siena S, Schiavo R, Pedrazzoli P, Carlo-Stella C
Abstract excerpt
PURPOSE: To review recent advances in peripheral-blood progenitor-cell (PBPC) transplantation in order to define the optimal cell dose required for autologous and allogeneic transplantation. MATERIALS AND METHODS: A search of MEDLINE was conducted to identify relevant publications. Their bibliographies were also used to identify further articles and abstracts for critical review. RESULTS: The CD34(+) cell content...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
